{
  "docId": "019de074-d3d5-753e-80c7-2426b111c999",
  "docSlug": "1ec46bbfcfe4d48ad79d6f74349ca67d",
  "documentTitle": "ATAI | Investor Conference Presentation Deck | 14 slides",
  "authorId": "atai",
  "authorName": "atai Life Sciences",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 9,
  "pageCount": 14,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide outlines a standard randomized controlled trial (RCT) flow.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-d3d5-753e-80c7-2426b111c999/9",
  "deckHref": "/decks/019de074-d3d5-753e-80c7-2426b111c999",
  "deckJsonHref": "/decks/019de074-d3d5-753e-80c7-2426b111c999.json",
  "deckAnchorHref": "/decks/019de074-d3d5-753e-80c7-2426b111c999#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.29,
        "x": 0.06,
        "y": 0.26
      },
      "kind": "callout",
      "text": "Primary Endpoint: MCCB neurocognitive composite score change from baseline at Week 6",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66e0f31d-f142-4f69-9ea2-da4d9e0847ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Phase 2b Proof-of-Concept Trial Design",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ac8002b9-778e-4608-84fd-925fee50fe01",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "paragraph",
      "text": "Trial status: FPI in 1Q'23, data anticipated H2'24",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15bab395-1b71-4568-b6a8-ecd4641a63d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Note: MCCB = MATRICS Consensus Cognitive Battery; VRFCAT = Virtual Reality Capacity Assessment Tool; TID = 3x/day dosing",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab84d393-8a12-4600-bc00-5c4d83aa2348",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "RL-007 Phase 2b trial design: randomized 6-week study of RL-007 20mg and 40mg vs placebo in 234 patients with CIAS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36d69dd6-528c-499a-bd44-4a120b91d4ea",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "32cd22e8-fbf1-4293-ab6b-44458c00b327",
      "evidence": "The slide uses a timeline-based process flow to represent trial stages.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 11,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d92986b5-4ee7-45b4-8f16-089e0860f348",
      "evidence": "The presentation highlights the unaddressed need in mental health disorders",
      "position": 0,
      "objective": "What is the cost of not addressing mental health disorders?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}